|
|
Volumn 14, Issue 4, 1999, Pages 735-737
|
|
ATS/ERS/WASOG statement on sarcoidosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
HYDROXYCHLOROQUINE;
METHOTREXATE;
BLOOD TOXICITY;
CARCINOGENICITY;
CLINICAL FEATURE;
CORTICOSTEROID THERAPY;
DRUG CHOICE;
EDITORIAL;
HUMAN;
IMMUNOPATHOGENESIS;
IMMUNOSUPPRESSIVE TREATMENT;
MUCOSA INFLAMMATION;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROGNOSIS;
SARCOIDOSIS;
TOPICAL DRUG ADMINISTRATION;
HUMANS;
PRACTICE GUIDELINES;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
SARCOIDOSIS, PULMONARY;
|
|
EID: 0032725411
PISSN: 09031936
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1399-3003.1999.14d02.x Document Type: Editorial |
|
Times cited : (446)
|
|
References (2)
|
